Inogen to Announce First Quarter 2020 Financial Results on Tuesday, May 5, 2020

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (877) 858-9805 for domestic callers or (201) 689-8550 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen’s website at: http://investor.inogen.com/.

A replay of the call will be available beginning, May 5, 2020 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on May 19, 2020. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Access Code: 13672721. The webcast will also be available on Inogen’s website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

Contacts

Investor Relations Contact:
Matt Bacso, CFA

805-879-8205

Media Contact:
Byron Myers

805-562-0503

Staff

Recent Posts

WELL Health Announces Delay in Filing of Annual Audited Financial Statements Due to Matter Related to US Subsidiary Circle Medical

VANCOUVER, BC, March 28, 2025 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF)…

9 hours ago

Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy

The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring…

15 hours ago

SimonMed Imaging Provides Notice of Security Incident

SCOTTSDALE, Ariz., March 28, 2025 /PRNewswire/ -- SimonMed Imaging confirmed that it experienced a data incident…

15 hours ago

Sohar Health Lands $3.8M to Open the Front Door to Faster, Fairer Care

Kindred Capital backs Sohar Health's mission to remove one of care's biggest hidden barriers and…

15 hours ago

FemTech Leaders Willow and Elvie Unite to Advance the Next Revolution in Maternal Health

Willow acquires Elvie to develop a global multi-category platform offering a diverse range of maternal…

15 hours ago

Dräger and VirtualiSurg receive Obsidian Award for Babyleo XR extended reality simulator.

Award honors groundbreaking innovations in extended reality across reality platforms, spanning hardware, software and content…

15 hours ago